Abstract

Preeclampsia is caused by placental hypoxia and systemic inflammation and is associated with reduced placental growth factor (PlGF) and endothelial nitric oxide synthase (eNOS) levels. The molecular signaling axes involved in this process may play a role in the pathogenesis of preeclampsia. Here, we found that hypoxic exposure increased hypoxia-inducible factor-1α (HIF-1α)/Twist1-mediated miR-214-3p biogenesis in trophoblasts, suppressing PlGF production and trophoblast invasion. TNF-α stimulation increased NF-κB-dependent miR-214-3p expression in endothelial cells, impairing eNOS expression and causing endothelial dysfunction. Synthetic miR-214-3p administration to pregnant mice decreased PlGF and eNOS expression, resulting in preeclampsia-like symptoms, including hypertension, proteinuria, and fetal growth restriction. Conversely, miR-214-3p deletion maintained the PlGF and eNOS levels in hypoxic pregnant mice, alleviating preeclampsia-like symptoms and signs. These findings provide new insights into the role of HIF-1/Twist1- and NF-κB-responsive miR-214-3p-dependent PlGF and eNOS downregulation in the pathogenesis of preeclampsia and establish miR-214-3p as a therapeutic or preventive target for preeclampsia and its complications.

Hypoxia-induced miR-214-3p: key player in preeclampsia pathogenesis

This research investigates how a molecule, miR-214-3p, impacts the occurrence of preeclampsia - a pregnancy issue marked by high blood pressure and organ damage. Scientists discovered that miR-214-3p produced more when oxygen levels are low, suppresses two other molecules, PlGF and eNOS, essential for a healthy pregnancy. In mouse experiments, artificially increasing miR-214-3p led to preeclampsia-like symptoms, while mice without miR-214-3p alleviated these symptoms in low oxygen. This suggests miR-214-3p could be a focus for preeclampsia prevention or treatment. Further studies are required to confirm this. “This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.”

Details

Title
Alleviation of preeclampsia-like symptoms through PlGF and eNOS regulation by hypoxia- and NF-κB-responsive miR-214-3p deletion
Author
Kim, Suji 1 ; Shim, Sungbo 2 ; Kwon, Jisoo 3 ; Ryoo, Sungwoo 4 ; Byeon, Junyoung 5 ; Hong, Jungwoo 5 ; Lee, Jeong-Hyung 5 ; Kwon, Young-Guen 6 ; Kim, Ji-Yoon 3 ; Kim, Young-Myeong 1   VIAFID ORCID Logo 

 Kangwon National University, Department of Molecular and Cellular Biochemistry, School of Medicine, Chuncheon, Republic of Korea (GRID:grid.412010.6) (ISNI:0000 0001 0707 9039) 
 Chungbuk National University, Department of Biochemistry, Cheongju, Republic of Korea (GRID:grid.254229.a) (ISNI:0000 0000 9611 0917) 
 Hanyang University College of Medicine, Department of Anesthesiology and Pain Medicine, Hanyang University Hospital, Seoul, Republic of Korea (GRID:grid.49606.3d) (ISNI:0000 0001 1364 9317) 
 Kangwon National University, Department of Biological Sciences, Chuncheon, Republic of Korea (GRID:grid.412010.6) (ISNI:0000 0001 0707 9039) 
 Kangwon National University, Department of Biochemistry, College of Natural Sciences, Chuncheon, Republic of Korea (GRID:grid.412010.6) (ISNI:0000 0001 0707 9039) 
 Curacle Co. Ltd, Advanced Institute of Technology, Seoul, Republic of Korea (GRID:grid.412010.6) 
Pages
1388-1400
Publication year
2024
Publication date
Jun 2024
Publisher
Springer Nature B.V.
ISSN
12263613
e-ISSN
20926413
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3083281207
Copyright
© The Author(s) 2024. corrected publication 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.